These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10931157)

  • 21. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
    Li Q; Nakadai A; Takeda K; Kawada T
    Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
    Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
    J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFNalpha2b stimulated release of IFNgamma differentially regulates T cell and NK cell mediated tumor cell cytotoxicity.
    Bose A; Baral R
    Immunol Lett; 2007 Jan; 108(1):68-77. PubMed ID: 17112599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased tumor surveillance in perforin-deficient mice.
    van den Broek ME; Kägi D; Ossendorp F; Toes R; Vamvakas S; Lutz WK; Melief CJ; Zinkernagel RM; Hengartner H
    J Exp Med; 1996 Nov; 184(5):1781-90. PubMed ID: 8920866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis.
    Lee RK; Spielman J; Podack ER
    Int Immunol; 1996 Jul; 8(7):991-1000. PubMed ID: 8757944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical contribution of liver natural killer T cells to a murine model of hepatitis.
    Takeda K; Hayakawa Y; Van Kaer L; Matsuda H; Yagita H; Okumura K
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5498-503. PubMed ID: 10792025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome.
    Rafi AQ; Zeytun A; Bradley MJ; Sponenberg DP; Grayson RL; Nagarkatti M; Nagarkatti PS
    J Immunol; 1998 Sep; 161(6):3077-86. PubMed ID: 9743374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.
    Lee RK; Spielman J; Zhao DY; Olsen KJ; Podack ER
    J Immunol; 1996 Sep; 157(5):1919-25. PubMed ID: 8757310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced natural killer (NK) cell activity and NK-sensitive thymic cells in murine muscular dystrophy.
    Semple JW; Szewczuk MR
    Cell Immunol; 1983 Dec; 82(2):316-25. PubMed ID: 6652689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.
    Kawano T; Cui J; Koezuka Y; Toura I; Kaneko Y; Sato H; Kondo E; Harada M; Koseki H; Nakayama T; Tanaka Y; Taniguchi M
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5690-3. PubMed ID: 9576945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
    Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
    Immunology; 2000 Feb; 99(2):229-34. PubMed ID: 10692041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperthermia suppresses the cytotoxicity of NK cells via down-regulation of perforin/granzyme B expression.
    Koga T; Harada H; Shi TS; Okada S; Suico MA; Shuto T; Kai H
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1319-23. PubMed ID: 16236268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship of natural killer cell counts, perforin mRNA and CD2 expression to post-exercise natural killer cell activity in humans.
    Miles MP; Mackinnon LT; Grove DS; Williams NI; Bush JA; Marx JO; Kraemer WJ; Mastro AM
    Acta Physiol Scand; 2002 Apr; 174(4):317-25. PubMed ID: 11942919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance and augmentation of innate immunity in mice exposed to starvation.
    Shen J; Ren H; Tomiyama-Miyaji C; Watanabe M; Kainuma E; Inoue M; Kuwano Y; Abo T
    Cell Immunol; 2009; 259(1):66-73. PubMed ID: 19595299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perforin dependence of natural killer cell-mediated tumor control in vivo.
    van den Broek MF; Kägi D; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3514-6. PubMed ID: 8566046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of perforin-independent NK cell-mediated cytotoxicity.
    Wallin RP; Screpanti V; Michaëlsson J; Grandien A; Ljunggren HG
    Eur J Immunol; 2003 Oct; 33(10):2727-35. PubMed ID: 14515256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum.
    Smyth MJ; Kelly JM; Baxter AG; Körner H; Sedgwick JD
    J Exp Med; 1998 Nov; 188(9):1611-9. PubMed ID: 9802973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
    Stenström M; Sköld M; Andersson A; Cardell SL
    Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.